KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Common Equity (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Common Equity readings, the most recent being $51.9 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 5.22% to $51.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $51.9 billion, a 5.22% increase, with the full-year FY2025 number at $53.4 billion, up 7.78% from a year prior.
  • Common Equity hit $51.9 billion in Q1 2026 for Thermo Fisher Scientific, down from $53.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $53.4 billion in Q4 2025 to a low of $41.0 billion in Q2 2022.
  • Median Common Equity over the past 5 years was $46.7 billion (2023), compared with a mean of $46.9 billion.
  • Biggest five-year swings in Common Equity: rose 16.97% in 2022 and later rose 3.15% in 2023.
  • Thermo Fisher Scientific's Common Equity stood at $44.0 billion in 2022, then rose by 6.11% to $46.7 billion in 2023, then increased by 6.05% to $49.6 billion in 2024, then rose by 7.78% to $53.4 billion in 2025, then fell by 2.76% to $51.9 billion in 2026.
  • The last three reported values for Common Equity were $51.9 billion (Q1 2026), $53.4 billion (Q4 2025), and $51.0 billion (Q3 2025) per Business Quant data.